The Neglected Catheter: Peripheral Vascular Access Device‐Related Infection: Clinical and Legal Perspectives

“Up to 90% of hospitalized patients can require a PVAD during their stay, however, greater than 60% of PVADs fail due to dislodgement, phlebitis, occlusion, infiltration, or infection.”¹ PVAD infections are so prevalent that the topic “Infections from Peripherally Inserted IV Lines” became number 9 in the ECRI Institute’s 2019 Top 10 Patient Safety Concerns.…

Details

Does a Patient’s Socioeconomic Status Influence Their Risk for SSI?

The access to, use of, and quality of health care can vary based on socioeconomic status, which can be measured by income, education, and/or occupation.1,2 Socioeconomic factors can be associated with various health outcomes, one of them being surgical site infection (SSI) which affects up to 5% of surgical procedures nationwide.3 However, the association between…

Details

Top 5 Takeaways on Infection Preventionist Collaboration with the Surgical Team

Surgical site infection (SSI) is a significant postoperative complication that increases morbidity, mortality, and length of stay for surgical patients[1]. On average, 300,000 to 500,000 people develop SSI annually in the United States[1], with 3% of SSIs being fatal and an overall national cost of $10 billion per year[2]. Reducing the risk of SSI begins…

Details

Reducing CLABSI and MARSI Risk Through Improved Vascular Access Dressing Integrity

Vascular Access Dressing Adherence and Hospital-acquired Infections Central venous access device (CVAD) related infections have a 12‐25% mortality in ICU populations. [1] Due to dressing disruption, central line‐associated bloodstream infection (CLABSI) may occur. The US Centers for Disease Control and Prevention (CDC) and the Infusion Nurses Society (INS) agree that vascular access device (VAD) dressing…

Details

3 Questions with Jack LeDonne, MD, FACS, VA-BC

Our newest edition of 3 Questions With… 3 Questions With… features some of the finest thought leaders in healthcare specialties such as Infection Prevention, Vascular Access, Surgical Care and more. These experts answer questions on the latest insights, evidence and current practices. For our newest 3 Questions With… Eloquest Healthcare is proud to feature Jack…

Details

3 Questions with Russ Nassof, JD

Our newest edition of 3 Questions With… 3 Questions With… features some of the finest thought leaders in healthcare specialties such as Infection Prevention, Vascular Access, Surgical Care and more. These experts answer questions on the latest insights, evidence and current practices. For our newest 3 Questions With… Eloquest Healthcare is proud to feature Russell…

Details

Partnering for Patient Safety: Eloquest Healthcare and the Patient Safety Movement

Preventable deaths in the US A 2016 study at Johns Hopkins University School of Medicine found that preventable deaths in hospitals are the third leading cause of death in the US behind heart disease and cancer.[1] The study suggests that medical error leads to more than 250,000 deaths each year in the US, though other…

Details

3 Questions with Michelle Devries MPH, CIC, VA-BC

We are excited to launch a new production, a video series entitled, “3 Questions With…” 3 Questions With… features some of the finest thought leaders in healthcare specialties such as Infection Prevention, Vascular Access, Surgical Care and more. These experts answer questions on the latest insights, evidence and current practices. For our premier 3 Questions…

Details